Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy
Bladder Cancer · 07.01.2016 · 2 (1) · 101-109
DOI: 10.3233/blc-150033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 07.01.2016. Verfasst von P J Boström und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, University of Toronto and Princess Margaret Hospital (University Health Network), Toronto, ON, Canada; Department of…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Tumour hypoxia, which is frequent in many cancer types, is associated with treatment resistance and poor prognosis. The role of hypoxia in surgically treated bladder cancer (BC) is not well described. We studied the role of hypoxia in two independent series of urothelial bladder cancers treated with radical cystectomy.
Methods
279 patients from the University Hospital Network (UHN), Toronto, Canada, and Turku University, Finland were studied. Hypoxia biomarkers (HIF1-α, CAIX, GLUT-1) and proliferation marker Ki-67 were analyzed with immunohistochemistry using defined tissue microarrays. Kaplan-Meier methods and Cox proportional hazards regression models were used to investigate prognostic role of the factors.
Results
In univariate analyses, strong GLUT-1 positivity and a high Ki-67 index were associated with poor survival. In multivariate model containing clinical prognostic variables, GLUT-1 was an independent prognostic factor associated with worse disease-specific survival (HR 2.9, 95% CI 0.7–12.6, Wald p = 0.15 in the Toronto cohort and HR 3.2, 95% CI 1.3–7.5, Wald p = 0.0085 in the Turku cohort).
Conclusion
GLUT-1 is frequently upregulated and is an independent prognostic factor in surgically treated bladder cancer. Further studies are needed to evaluate the potential role of hypoxia-based and targeted therapies in hypoxic bladder tumours.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, University of Toronto and Princess Margaret Hospital (University Health Network), Toronto, ON, Canada; Department of Urology, Turku University Hospital, Turku, Finland.
- Department of Radiation Oncology, University of Toronto and Princess Margaret Hospital (University Health Network) , Toronto, ON, Canada.
- Department of Biostatistics, University of Toronto and Princess Margaret Hospital (University Health Network) , Toronto, ON, Canada.
- Department of Pathology, University of Toronto and Princess Margaret Hospital (University Health Network) , Toronto, ON, Canada.
- Department of Surgical Oncology, University of Toronto and Princess Margaret Hospital (University Health Network) , Toronto, ON, Canada.
- Department of Pathology, Helsinki University Hospital, Helsinki, Finland; Institute for Molecular Medicine (FIMM), Helsinki, Finland.
Zitieren
APA
Boström, P. J., Thoms, J., Sykes, J., Ahmed, O., Evans, A., van Rhijn, B. W., Mirtti, T., Stakhovskyi, O., Laato, M., Margel, D., Pintilie, M., Kuk, C., Milosevic, M., Zlotta, A. R., & Bristow, R. G. (2016). Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer, 2(1), 101-109. https://doi.org/10.3233/blc-150033
Vancouver
Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, et al. Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2016;2(1):101-109. doi:10.3233/blc-150033
BibTeX
@article{Bostrm2016,
author = {Boström, P J and Thoms, J and Sykes, J and Ahmed, O and Evans, A and van Rhijn, B W G and Mirtti, T and Stakhovskyi, O and Laato, M and Margel, D and Pintilie, M and Kuk, C and Milosevic, M and Zlotta, A R and Bristow, R G},
title = {Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy},
journal = {Bladder Cancer},
year = {2016},
volume = {2},
number = {1},
pages = {101--109},
doi = {10.3233/blc-150033}
}
EUVIMED